Trial Summary
What is the purpose of this trial?The purpose of this study is to see if we can find ways to improve the treatment of tobacco dependence in patients who have cancer or may have cancer. We will compare two ways to help people quit tobacco use before surgery and to stay quit after surgery. One way is a scheduled reduced smoking program followed by use of the nicotine patch. In this program, the tobacco user will gradually cut down on their tobacco use until they quit. Once they quit, they will be offered the nicotine patch. We will compare this approach to our current program of counseling and use of nicotine patch. What we learn from this study may help us to develop new ways to help tobacco users and improve our current smoking cessation program.
Eligibility Criteria
This trial is for adults over 18 with cancer or a mass that might be cancer, who are not in the distant metastatic stage and are candidates for surgery in no less than 7 days. Participants must be mentally sound, able to use a phone and PDA, willing to consent, and smoke more than 8 cigarettes daily or frequently use other tobacco.Inclusion Criteria
I am 18 years old or older.
I have cancer or a mass that may be cancer, but it has not spread far from where it started.
I do not have any severe mental health issues or cognitive impairments.
Treatment Details
The study compares two smoking cessation methods before surgery: one uses scheduled reduced smoking plus nicotine patches; the other employs hospital counseling alongside nicotine patches. The goal is to determine which method better helps patients quit tobacco use pre- and post-surgery.
2Treatment groups
Experimental Treatment
Active Control
Group I: 2Experimental Treatment1 Intervention
Hospital Counseling + Nicotine Replacement Therapy + Pre-surgical Schedule Reduced Smoking (HC+NRT+PS/SRS)
Group II: 1Active Control1 Intervention
Hospital Counseling + Nicotine Replacement Therapy (HC+NRT)
Find a clinic near you
Research locations nearbySelect from list below to view details:
Memorial Sloan Kettering Cancer CenterNew York, NY
Loading ...
Who is running the clinical trial?
Memorial Sloan Kettering Cancer CenterLead Sponsor
M.D. Anderson Cancer CenterCollaborator